Clear Harbor Asset Management, LLC Kymera Therapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 10,000 shares of KYMR stock, worth $366,300. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$366,300
Previous $473,000
15.01%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
65.1MCall Options Held
50.6KPut Options Held
50.3K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$252 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$220 Million3.04% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$194 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$189 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$189 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...